ATE116982T1 - 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine. - Google Patents

1-indolylalkyl-4-(substituierte pyridinyl)- piperazine.

Info

Publication number
ATE116982T1
ATE116982T1 AT89110485T AT89110485T ATE116982T1 AT E116982 T1 ATE116982 T1 AT E116982T1 AT 89110485 T AT89110485 T AT 89110485T AT 89110485 T AT89110485 T AT 89110485T AT E116982 T1 ATE116982 T1 AT E116982T1
Authority
AT
Austria
Prior art keywords
hydrogen
independently selected
indolylalkyl
piperazine
substituted pyridinyl
Prior art date
Application number
AT89110485T
Other languages
English (en)
Inventor
David William Smith
Frank D Yocca
Joseph Paul Yevich
Ronald John Mattson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE116982T1 publication Critical patent/ATE116982T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M6/00—Primary cells; Manufacture thereof
    • H01M6/04—Cells with aqueous electrolyte
    • H01M6/06—Dry cells, i.e. cells wherein the electrolyte is rendered non-fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M4/00—Electrodes
    • H01M4/02—Electrodes composed of, or comprising, active material
    • H01M4/62—Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
    • H01M4/621—Binders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT89110485T 1988-06-10 1989-06-09 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine. ATE116982T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20484588A 1988-06-10 1988-06-10
US07/338,253 US4954502A (en) 1988-06-10 1989-04-14 1-indolyalkyl-4-(substituted-pyridinyl)piperazines

Publications (1)

Publication Number Publication Date
ATE116982T1 true ATE116982T1 (de) 1995-01-15

Family

ID=26899839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89110485T ATE116982T1 (de) 1988-06-10 1989-06-09 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine.

Country Status (17)

Country Link
US (1) US4954502A (de)
EP (1) EP0345808B1 (de)
JP (1) JP2786480B2 (de)
KR (1) KR0128210B1 (de)
AT (1) ATE116982T1 (de)
AU (1) AU624147B2 (de)
CA (1) CA1337421C (de)
CY (1) CY1846A (de)
DE (1) DE68920482T2 (de)
DK (1) DK283589A (de)
ES (1) ES2067500T3 (de)
FI (1) FI95698C (de)
HK (1) HK83295A (de)
IE (1) IE66569B1 (de)
NO (1) NO174296C (de)
PT (1) PT90805B (de)
SG (1) SG32583G (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120843A (en) * 1987-04-27 1992-06-09 Upjohn Pharmaceutically active amines
US4975445A (en) * 1989-12-06 1990-12-04 Warner-Lambert Company Substituted cyclohexenes as central nervous system agents
HUT61296A (en) * 1989-12-28 1992-12-28 Upjohn Co Process for producing substituted diaromatic compounds against aids and pharmaceutical compositions comprising same
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
US5270312A (en) * 1990-11-05 1993-12-14 Warner-Lambert Company Substituted piperazines as central nervous system agents
US5124332A (en) * 1991-01-28 1992-06-23 Warner-Lambert Company Substituted indoles as central nervous system agents
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals
US5145973A (en) * 1991-09-30 1992-09-08 Union Carbide Chemicals & Plastics Technology Corporation Oxa-Bicyclic polyfunctional compounds and preparation thereof
US5206393A (en) * 1991-09-30 1993-04-27 Union Carbide Chemicals & Plastics Technology Corporation Oxa-bicyclic polyfunctional compounds and preparation thereof
US5314896A (en) * 1991-11-20 1994-05-24 Warner-Lambert Company 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
CA2091204C (en) * 1992-03-11 1997-04-08 Ronald J. Mattson Antiischemic-piperazinyl and piperidinyl-cyclohexanes
KR950704252A (ko) * 1992-12-21 1995-11-17 우에하라 아키라 N-치환 이미다졸 유도체
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5391570A (en) * 1993-10-14 1995-02-21 Bristol-Myers Squibb Aminomethyl-benzodioxane and benzopyran serotonergic agents
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
AU5343498A (en) * 1997-01-21 1998-08-07 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compounds and medicinal use thereof
US6150533A (en) * 1998-04-08 2000-11-21 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
AU3479299A (en) * 1998-04-08 1999-10-25 American Home Products Corporation N-aryloxyethyl-indoly-alkylamines for the treatment of depression
TW520367B (en) * 1998-04-29 2003-02-11 Wyeth Corp Indolyl derivatives as serotonergic agents
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
HUP0200309A3 (en) * 1999-01-07 2003-05-28 Wyeth Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
BR9916618A (pt) * 1999-01-28 2001-10-23 Bristol Myers Squibb Co Compostos heterocìclicos antidepressivos
US7265115B2 (en) 1999-01-29 2007-09-04 Abbott Laboratories Diazabicyclic CNS active agents
BR0015425A (pt) * 1999-11-08 2002-07-16 Wyeth Corp N-aril-( homopiperazinil )-ciclohexilaminas como transportadoras de 5-ht
EP1181294B1 (de) 2000-03-31 2004-03-31 Sanochemia Pharmazeutika Aktiengesellschaft Neue derivate und analoga von galanthamin
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
US6552015B2 (en) * 2000-08-03 2003-04-22 Pfizer Inc. Azabicycloalkane derivatives and therapeutic uses thereof
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
AU2426602A (en) * 2000-11-20 2002-05-27 Biovitrum Ab Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
US8013156B2 (en) 2003-03-19 2011-09-06 Exelixis, Inc. Tie-2 modulators and methods of use
AU2006204522A1 (en) * 2005-01-03 2006-07-13 Universita Degli Studi Di Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
ES2302671T1 (es) * 2006-08-29 2008-08-01 Teva Pharmaceutical Industries Ltd. Procedimientos para la sintesis de 5-fenil-1-tritil-1h-tetrazol.
AU2009225025A1 (en) * 2008-03-14 2009-09-17 Merck Patent Gmbh Azaindole compounds for treatment of central nervous system disorders
CN104163813B (zh) * 2013-05-16 2017-02-01 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
EP3027607B1 (de) 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Substituierte heteroarylverbindungen und verfahren zur verwendung davon
CN104725363B (zh) * 2013-12-20 2019-03-01 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
US9714232B2 (en) * 2013-12-20 2017-07-25 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use thereof
WO2016192657A1 (en) * 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
CN106795143B (zh) * 2015-08-13 2019-05-24 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
EP3687989B1 (de) 2017-09-29 2024-02-28 Sunshine Lake Pharma Co., Ltd. Substituierte pyrimidinpiperazinverbindung und verwendung davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (de) * 1959-09-25 1900-01-01
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
US3472855A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((benz(g)-indolyl)-lower-alkyl)-4-substituted-piperazines
US4302589A (en) * 1980-05-08 1981-11-24 American Cyanamid Company Cis-mono and disubstituted-2-methyl-3-[(piperazinyl) and (piperidino)ethyl]indolines, intermediates for their preparation and methods of preparation

Also Published As

Publication number Publication date
FI95698C (fi) 1996-03-11
KR910000708A (ko) 1991-01-30
KR0128210B1 (ko) 1998-04-02
PT90805A (pt) 1989-12-29
NO174296B (no) 1994-01-03
DE68920482D1 (de) 1995-02-23
CA1337421C (en) 1995-10-24
AU3628289A (en) 1989-12-14
PT90805B (pt) 1994-10-31
AU624147B2 (en) 1992-06-04
DK283589A (da) 1989-12-11
US4954502A (en) 1990-09-04
JP2786480B2 (ja) 1998-08-13
FI892787A (fi) 1989-12-11
FI95698B (fi) 1995-11-30
NO174296C (no) 1994-04-13
SG32583G (en) 1995-09-01
DE68920482T2 (de) 1995-06-01
NO892381L (no) 1989-12-11
EP0345808B1 (de) 1995-01-11
HK83295A (en) 1995-06-01
DK283589D0 (da) 1989-06-09
CY1846A (en) 1996-03-08
EP0345808A1 (de) 1989-12-13
IE66569B1 (en) 1996-01-24
FI892787A0 (fi) 1989-06-07
JPH0285277A (ja) 1990-03-26
IE891861L (en) 1989-12-10
NO892381D0 (no) 1989-06-09
ES2067500T3 (es) 1995-04-01

Similar Documents

Publication Publication Date Title
ATE116982T1 (de) 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine.
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
ES2045109T3 (es) 1-fenil-3-naftaleniloxipropanaminas.
DK249089D0 (da) Benzamid-forbindelser, der er nyttige som protease-inhibitorer
IL93443A0 (en) Trifluoromethylphenylazolyl-methyloxirane derivatives and fungicides containing these compounds
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
DE3772015D1 (de) Chinolinverbindung.
IN165718B (de)
ATE86860T1 (de) Praeparat gegen ulcus.
ATE84028T1 (de) Biologisch aktive verbindungen.
NO875357L (no) Kjemiske sammensetninger og deres bruk som brennstoffadditiver.
ES2003086A6 (es) Procedimiento de obtencion de tienoquinolicinsulfonamidas
DE68905406D1 (de) Chinolin-verbindung.
DE3781986D1 (de) Substituierte chinoxaline.
DE3778088D1 (de) Substituierte pyrimidochinoxaline.
DE69112095D1 (de) 1-Phenoxycarbonyl-2-Pyrrolidon-Derivate und nootrope Wirkstoffe.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time